Chih-Po Chiang

Prof. Chih-Po Chiang

Division of Breast Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan
+1
orcid
Department of Biomedical Sciences, Chung Shan Medical Univer...

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
Chih-Po ChiangChih-Po Chiang
Chih-Po Chiang
MHMing-Feng Hou
Ming-Feng Hou
WHWen-Chun Hung
Wen-Chun Hung

28 January 2010 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Chih-Po ChiangChih-Po Chiang
Chih-Po Chiang
CWChie‐Hong Wang
Chie‐Hong Wang
HCHui‐Chiu Chang
Hui‐Chiu Chang
SMShivaji V. More
Shivaji V. More
WLWen-Shan Li
Wen-Shan Li
WHWen-Chun Hung
Wen-Chun Hung

2 July 2013 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
HLH-Y Lin
H-Y Lin
Chih-Po ChiangChih-Po Chiang
Chih-Po Chiang
WHWen-Chun Hung
Wen-Chun Hung
Signal transducer and activator of transcription 3 (STAT3) activation is frequently found in human lung cancer and is associated with increased metastasis and reduced survival. How STAT3 enhances invasiveness is unclear. The expression of microRNAs and target genes was measured by real-time RT–PCR. Protein level was studied by western blotting. Luciferase reporter assay was used to confirm the direct targeting of microRNAs. Gelatin zymography was used to study matrix metalloproteinase (MMP) activity. Transwell assay was used to investigate cell migration and invasion. Enforced expression of STAT3 decreases the endogenous MMP inhibitor RECK protein but not mRNA level in H460 cells. Conversely, STAT3 inhibitor S3I-201 increases RECK protein in STAT3-activating H1299 cells. We demonstrate that STAT3 upregulates miR-92a to repress RECK via post-transcriptional inhibition. The RECK 3′-untranslated region (3′UTR) reporter activity assay suggests that RECK is a direct repression target of miR-92a. Delivery of pre-miR-92a reduces RECK protein level whereas transfection of anti-miR-92a restores STAT3-induced downregulation of RECK. Anti-miR-92a attenuates MMP activity, migration and invasion of H1299 cells and STAT3-overexpressing H460 cells, suggesting miR-92a is critical for STAT3-induced invasiveness. The STAT3-induced miR-92a promotes cancer invasion by suppressing RECK and targeting of the STAT3/miR-92a axis may be helpful for cancer treatment.

27 October 2021 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
MHMing-Feng Hou
Ming-Feng Hou
FOFu Ou-Yang
Fu Ou-Yang
CLChung-Liang Li
Chung-Liang Li
FCFang-Ming Chen
Fang-Ming Chen
CCChieh-Han Chuang
Chieh-Han Chuang
Chih-Po ChiangChih-Po Chiang
Chih-Po Chiang
In Western countries, breast cancer tends to occur in older postmenopausal women. However, in Asian countries, the proportion of younger premenopausal breast cancer patients is increasing. Increasing evidence suggests that the gut microbiota plays a critical role in breast cancer. However, studies on the gut microbiota in the context of breast cancer have mainly focused on postmenopausal breast cancer. Little is known about the gut microbiota in the context of premenopausal breast cancer. This study aimed to comprehensively explore the gut microbial profiles, diagnostic value, and functional pathways in premenopausal breast cancer patients. Here, we analyzed 267 breast cancer patients with different menopausal statuses and age-matched female controls. The α-diversity was significantly reduced in premenopausal breast cancer patients, and the β-diversity differed significantly between breast cancer patients and controls. By performing multiple analyses and classification, 14 microbial markers were identified in the different menopausal statuses of breast cancer.Bacteroides fragiliswas specifically found in young women of premenopausal statuses andKlebsiella pneumoniaein older women of postmenopausal statuses. In addition, menopausal-specific microbial markers could exhibit excellent discriminatory ability in distinguishing breast cancer patients from controls. Finally, the functional pathways differed between breast cancer patients and controls. Our findings provide the first evidence that the gut microbiota in premenopausal breast cancer patients differs from that in postmenopausal breast cancer patients and shed light on menopausal-specific microbial markers for diagnosis and investigation, ultimately providing a noninvasive approach for breast cancer detection and a novel strategy for preventing premenopausal breast cancer.

5 September 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
CSChing-Tang Shih
Ching-Tang Shih
YYYao-Tsung Yeh
Yao-Tsung Yeh
CLChing-Chiang Lin
Ching-Chiang Lin
LYLin-Yu Yang
Lin-Yu Yang
Chih-Po ChiangChih-Po Chiang
Chih-Po Chiang
Patients with refractory diabetes are defined as type 2 diabetes (T2D) patients; they cannot achieve optimal glycemic control and exhibit persistent elevations of hemoglobin A1c (HbA1c) ≥8% while on appropriate therapy. Hyperglycemia can lead to severe microvascular/macrovascular complications. However, in contrast to T2D, few studies have focused specifically on the gut microbiota in refractory diabetes. To examine this issue, we recruited 79 subjects with T2D and refractory diabetes (RT2D), and all subjects received standard therapy with Metformin or other hypoglycemic agents with or without insulin for at least one year. The α-diversity displayed no significant difference, whereas the β-diversity showed a marginal significance (p = 0.054) between T2D and RT2D. The evaluation of taxonomic indices revealed reductions in both Akkermansia muciniphila and Fusobacterium and a corresponding enrichment of Bacteroides vulgatus, Veillonella denticariosi among those with RT2D. These microbial markers distinguished RT2D from T2D with an acceptable degree of discrimination (area under the curve (AUC) = 0.719, p < 0.01) and were involved in several glucose-related functional pathways. Furthermore, the relative abundance of Akkermansia muciniphila was negatively correlated with HbA1c. Our combined results reveal unique features of the gut microbiota in RT2D and suggest that the evaluation of the gut microbiota could provide insights into the mechanisms underlying glycemic control and the impact of therapeutic modalities in patients with RT2D.